These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11596595)

  • 41. Advances in adjuvant chemotherapy for colon cancer.
    Nelson H
    Minerva Chir; 1992 Mar; 47(5):213-22. PubMed ID: 1594115
    [No Abstract]   [Full Text] [Related]  

  • 42. 5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer.
    Hamilton JM; Sznol M; Friedman MA
    Important Adv Oncol; 1990; ():115-30. PubMed ID: 2182515
    [No Abstract]   [Full Text] [Related]  

  • 43. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
    Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mangafodipir as a cytoprotective adjunct to chemotherapy--a case report.
    Yri OE; Vig J; Hegstad E; Hovde O; Pignon I; Jynge P
    Acta Oncol; 2009; 48(4):633-5. PubMed ID: 19169914
    [No Abstract]   [Full Text] [Related]  

  • 45. [Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage III colon cancer].
    Miyake Y; Ikeda K; Osawa H; Nagase H; Hoshi M; Doi T; Makari Y; Oshima S; Iijima S; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2161-3. PubMed ID: 23268010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant therapy for colorectal cancer: the NSABP clinical trials.
    Wolmark N
    Adv Exp Med Biol; 1988; 244():261-6. PubMed ID: 3073660
    [No Abstract]   [Full Text] [Related]  

  • 47. Accrual delayed in adjuvant bevacizumab trial.
    Tuma RS
    J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
    [No Abstract]   [Full Text] [Related]  

  • 48. [Adjuvant chemotherapy of colonic cancer].
    Shparyk IaV; Bilyns'kyĭ BT
    Klin Khir; 1995; (6):38-41. PubMed ID: 8673884
    [No Abstract]   [Full Text] [Related]  

  • 49. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
    Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
    PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Research by collaboration.
    Laupacis A
    Lancet; 1995 Apr; 345(8955):938. PubMed ID: 7715290
    [No Abstract]   [Full Text] [Related]  

  • 51. Chemotherapy of breast cancer in the older patient.
    Muss HB
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):14-6. PubMed ID: 7863346
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of chemotherapy and adjuvant therapy in the management of colorectal cancer.
    Forman WB
    Cancer; 1994 Oct; 74(7 Suppl):2151-3. PubMed ID: 8087782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].
    Schumacher K
    Strahlenther Onkol; 2000 May; 176(5):239-40. PubMed ID: 10847122
    [No Abstract]   [Full Text] [Related]  

  • 55. [The present status of CapeOX as adjuvant chemotherapy for colorectal cancer].
    Ishii K; Kanamoto A; Miyanaga S; Noto M; Takeda T; Tani T; Yagi M
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):319-22. PubMed ID: 25812500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant colon cancer chemotherapy: where we are and where we'll go.
    Lombardi L; Morelli F; Cinieri S; Santini D; Silvestris N; Fazio N; Orlando L; Tonini G; Colucci G; Maiello E
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S34-41. PubMed ID: 21129608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of advanced colon cancer responding to l-LV+5-FU as neoadjuvant chemotherapy].
    Ishiyama T; Nakamura T; Suzuki T; Inazawa K
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1097-9. PubMed ID: 15272593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
    Martenson JA; Willett CG; Sargent DJ; Mailliard JA; Donohue JH; Gunderson LL; Thomas CR; Fisher B; Benson AB; Myerson R; Goldberg RM
    J Clin Oncol; 2004 Aug; 22(16):3277-83. PubMed ID: 15249584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.